Mercantile Bank M&A Deal with Eastern Michigan Bank
Mercantile Bank Corporation has received regulatory approval from the FDIC and the Michigan Department of Insurance and Financial Services (DIFS) to merge Eastern Michigan Bank into Mercantile Bank. The approval allows for the conversion of Eastern Michigan Bank's twelve offices into Mercantile Bank branches, with the merger expected to close in the first quarter of 2027. This update follows the previously announced definitive agreement between the two Michigan-based banking organizations.
Viatris Signs $1.69B M&A Deal with Pacira BioSciences, Inc.
Viatris Inc. has completed its acquisition of Pacira BioSciences, Inc. for approximately $1.69 billion in cash. The transaction was executed via a tender offer for $36.50 per share followed by a merger, establishing Viatris as a leader in non-opioid pain management.
Value
$1.69B
Counterparty
Pacira BioSciences, Inc.
“Today marks an important milestone in the execution of our strategy to strengthen our U.S. innovative medicines business. With Pacira now part of Viatris, we are bringing together complementary portfolios, capabilities and expertise to establish a leadership position in non-opioid pain management. We are excited to welcome our new Pacira colleagues as we create new opportunities to make a meaningful difference for patients and accelerate our path to sustained revenue and earnings growth.”
Pacira BioSciences, Inc. completed its merger with Viatris Inc. on November 17, 2026, following a tender offer where Viatris acquired all outstanding shares for $36.50 per share in cash. As a result of the transaction, Pacira has become a wholly owned subsidiary of Viatris and entered into supplemental indentures to address its outstanding 2.125% Convertible Senior Notes due 2029.
Pulmatrix provided a status update on its pending merger with Eos SENOLYTIX, noting that the SEC has declared its Form S-4 registration statement effective and stockholders have approved the deal. The company expects the merger to close by the end of 2026, subject to Nasdaq listing approval and a planned reverse stock split.
Counterparty
Eos SENOLYTIX, Inc.
“Our focus in the third quarter and beyond has been to advance steps towards completing the proposed merger with Eos SENOLYTIX, a privately held biotechnology company developing novel gerotherapeutic peptides targeting mitochondrial dysfunction in aging-related diseases using the MitoXcel™ platform. To that end, we have obtained SEC effectiveness on our registration statement on Form S-4 in relation to the merger as well as approval from our stockholders on the proposed merger. We anticipate closing the proposed merger by the end of the year.”
Peter Ludlum, Interim Chief Executive Officer of Pulmatrix
Olin Corporation provided a status update on its pending merger with Huntsman Corporation, announcing the leadership structure and divisional organization for the combined entity, OlinHuntsman. The company appointed Philip M. Lister as CFO and established a four-division structure (Essential Chemicals, Polyurethanes, Advanced Solutions, and Winchester), with the merger expected to close in the first quarter of 2027.
Integer Holdings M&A Deal with Armstrong Parent, Inc.
Integer Holdings Corporation completed its merger with Armstrong Parent, Inc., an affiliate of KKR, becoming a wholly owned subsidiary. Shareholders of Integer are entitled to receive $127.00 in cash per share. In connection with the closing, the company entered into a new $2.1 billion credit agreement and issued supplemental indentures for its outstanding convertible senior notes.
MongoDB, Inc. has acquired Firebolt Analytics Inc. to integrate its high-performance analytics engine into the MongoDB Intelligent Data Platform. The acquisition aims to enable real-time analytics on live operational data without the need for separate data pipelines, supporting applications and AI agents that require sub-second query responses.
Axalta Coating Systems M&A Deal with Akzo Nobel N.V.
Axalta Coating Systems provided a status update on its pending merger of equals with AkzoNobel, specifically furnishing pro forma financial information related to a notes offering by an AkzoNobel subsidiary. The combined company, to be known as MergeCo, will be parented by AkzoNobel, with the merger remaining subject to final regulatory approvals and customary closing conditions.
Air Industries Group M&A Deal with Tenax Aerospace Acquisitions, LLC
Air Industries Group (AIRI) issued a press release disavowing financial illustrations and combined company projections released by its merger partner, Tenax Aerospace Acquisitions, LLC. The company stated that the information was released without its prior review or consent and that stockholders should not rely on the unauthorized pro forma data. The filing serves as a status update on the pending merger, noting that AIRI has not yet verified Tenax's financial results or provided its own 2026 estimates for the illustrations.
Crona Corp. completed the acquisition of 100% of the issued and outstanding ordinary shares of EC Journey Sdn. Bhd., a private limited company in Malaysia. The acquisition was completed without monetary consideration as the target was a dormant entity. Crona Corp. intends to use the new wholly owned subsidiary to develop software-related business activities.
UL Solutions Signs $350M M&A Deal with Worldly Holdings Inc.
UL Solutions Inc. has entered into a definitive agreement to acquire Worldly Holdings Inc., a supply chain intelligence software company, for an aggregate consideration of $350 million. The deal will be funded through a mix of cash, revolving credit, and approximately $127 million in Class A common stock. To offset the dilution from the stock issuance, UL Solutions also agreed to repurchase $130 million of its Class B common stock from its majority shareholder, UL Standards & Engagement.
Value
$350M
Counterparty
Worldly Holdings Inc.
“This acquisition will build on our supply chain intelligence capabilities and our expanding role in digital trust, helping customers gain greater visibility into where and how their products are made.”
Ftai Infrastructure Signs $255M M&A Deal with DRUbit Holdings LLC
FTAI Infrastructure's subsidiary, Drub LLC, completed the acquisition of DRUbit LLC from DRUbit Holdings LLC for an enterprise value of $255 million. As part of the transaction, the company assumed an existing $183.6 million secured term loan facility maturing in 2031 and entered into a new bridge loan credit agreement to fund the acquisition.
Inflection Point Acquisition Corp. VII Signs $70M M&A Deal with Elroy Air, Inc.
Inflection Point Acquisition Corp. VII (IPXG) provided a status update on its pending merger target, Elroy Air, which has signed a $70 million aircraft purchase agreement with Barq Group. The deal includes a firm order for five Chaparral cargo drones and 15 production slot reservations, supported by a $10.25 million initial deposit. This update follows the previously announced business combination agreement between Inflection Point and Elroy Air.
Evernorth Holdings M&A Deal with Pathfinder Digital Assets LLC
Evernorth Holdings Inc. filed an amendment to its original 8-K to provide required financial statements and pro forma information following the completion of its business combination with Pathfinder Digital Assets LLC and Arrington Capital SPAC I Inc. The merger was consummated on October 9, 2026, resulting in Evernorth becoming the public successor entity. The filing includes Pathfinder's unaudited financial statements showing a net loss of $3.73 million for the nine months ended September 30, 2026.
Aon plc has completed its $17.0 billion acquisition of USI, a leading provider of property and casualty and employee benefit solutions for the middle market. The deal establishes a premier U.S. middle-market platform and integrates USI's 10,500 team members and $3 billion in annual revenue into Aon's operations.
Value
$17B
Counterparty
USI
“Today marks an important step forward for our clients, colleagues and shareholders as we welcome USI to the Aon family and formally establish the premier U.S. middle-market platform.”
Greg Case, CEO of Aon
“With Aon’s distinctive capabilities and integrated, one-firm platform, we are entering an exciting new chapter for our colleagues and clients.”
Mike Sicard, President of Aon and global CEO of the middle market
Hormel Foods Signs $700M M&A Deal with Brakebush Brothers, LLC
Hormel Foods Corporation completed its acquisition of Brakebush Brothers, LLC on November 16, 2026. To fund the transaction, the company entered into a $1.0 billion delayed draw term loan facility and immediately borrowed $700 million to pay a portion of the purchase price.
Endra Life Sciences Signs $50M M&A Deal with Noble Africa LLC
ENDRA Life Sciences provided a status update on its pending merger with Noble Africa LLC, a subsidiary of ASP Isotopes Inc. The transaction, which includes a concurrent $50 million private placement, will result in Noble Africa becoming a wholly owned subsidiary and ENDRA being renamed 4K Resources Inc.
Value
$50M
Counterparty
Noble Africa LLC
“Our focus during the third quarter remained on completing the proposed merger with Noble Africa while managing ENDRA’s operating resources and liquidity to support transaction-related priorities.”
Alexander Tokman, Chairman and Chief Executive Officer of ENDRA Life Sciences
“The proposed transaction represents an important strategic opportunity for our stockholders. We continue to work with our merger counterparties to complete the remaining steps necessary to close the merger.”
Alexander Tokman, Chairman and Chief Executive Officer of ENDRA Life Sciences
Installed Building Products M&A Deal with Take Pride Insulation, LLC
Installed Building Products, Inc. (IBP) has acquired Take Pride Insulation, LLC, a Montana-based installer of spray foam, fiberglass, and rockwool insulation. The acquisition adds over $6 million in annual revenue and expands IBP's footprint in the Mountain West region. This deal brings IBP's total acquired annual revenue for 2026 to approximately $444 million.
Aethlon Medical M&A Deal with North Immunology, Inc.
Aethlon Medical provided a status update on its pending merger with North Immunology, Inc., originally announced on September 17, 2026. The filing includes an updated investor presentation that North Immunology will use in meetings with investors regarding the transaction and a concurrent private placement.
Standard Biotools M&A Deal with Treeline Biosciences, Inc.
Standard BioTools Inc. provided a status update regarding its pending acquisition of Treeline Biosciences, Inc., specifically addressing stockholder litigation and demand letters. To avoid potential business delays and moot disclosure claims, the company issued supplemental disclosures to its definitive proxy statement ahead of the special meeting of stockholders scheduled for November 19, 2026.
Diamondback Energy M&A Deal with Double Eagle IV Midco, LLC and Double Eagle V Midco, LLC
Diamondback Energy entered into a definitive agreement to acquire certain subsidiaries of Double Eagle for approximately $2.15 billion in cash and 15.56 million shares of common stock. The deal 'nets up' Diamondback's interest in a Midland Basin partnership it already co-owned, adding 176,000 net acres and significant undeveloped inventory. The acquisition is expected to close on December 21, 2026.
Counterparty
Double Eagle IV Midco, LLC and Double Eagle V Midco, LLC
Pool Corporation (POOL) has signed a definitive agreement to acquire Team Horner Group, Inc., a Florida-based wholesale distributor of swimming pool products. The acquisition includes 18 sales centers and manufacturing operations for pool heat pumps and salt chlorine generators. The deal is expected to close in Q1 2027 and will be funded through POOL's revolving credit facility and cash on hand.
Rapid Micro Biosystems M&A Deal with Merck KGaA, Darmstadt, Germany
Rapid Micro Biosystems has entered into a definitive merger agreement to be acquired by Merck KGaA, Darmstadt, Germany for $0.75 per share in an all-cash tender offer. Following the transaction, which is expected to close in December 2026, Rapid Micro Biosystems will become a wholly owned subsidiary of Merck KGaA's Life Science business. The deal aims to expand the reach of the Growth Direct platform for automated microbial quality control in pharmaceutical manufacturing.
Aytu Biopharma Signs $56M M&A Deal with Rosemont Pharmaceuticals Holdings, Inc.
Aytu BioPharma has entered into a definitive agreement to be acquired by Rosemont Pharmaceuticals Holdings, Inc. for $2.70 per share in cash, representing a total deal value of approximately $56 million. The transaction will be structured as a cash tender offer followed by a merger and is expected to close by the end of calendar 2026. The company also reported Q1 fiscal 2027 revenue of $14.8 million alongside the merger announcement.
Value
$56M
Counterparty
Rosemont Pharmaceuticals Holdings, Inc.
“Today, we announced that Aytu has entered into a definitive agreement to be acquired by Rosemont for $2.70 per share in cash. This agreement with Rosemont reflects the work our team has done to build our CNS and pediatric portfolio and earn the trust of the patients and healthcare providers we serve.”
Josh Disbrow, Chief Executive Officer of Aytu
“Importantly, we believe the transaction delivers compelling value to our shareholders and that, together, we can help more patients get the treatment they need.”
Hancock Whitney M&A Deal with Trustmark Corporation
Hancock Whitney Corporation has entered into a definitive agreement to acquire Trustmark Corporation in an all-stock merger. Trustmark shareholders will receive 0.7463 shares of Hancock Whitney common stock for each share of Trustmark they own. Following the merger, Trustmark Bank will be merged into Hancock Whitney Bank, and five Trustmark directors will join the Hancock Whitney board.
Aytu Biopharma M&A Deal with Rosemont Pharmaceuticals Holdings, Inc.
Aytu BioPharma has entered into a definitive agreement to be acquired by Rosemont Pharmaceuticals for $2.70 per share in an all-cash tender offer. The deal represents a 51.7% premium to Aytu's closing price on November 13, 2026, and is expected to close by the end of 2026. Upon completion, Aytu will become a wholly owned subsidiary of Rosemont, supporting Rosemont's U.S. growth strategy in the CNS and pediatric specialty pharmaceutical markets.
Datz World Holdings M&A Deal with RagingBull.com, LLC
DATZ World Holdings Corp. filed an amendment to its 8-K to provide required audited financial statements and pro forma financial information following its acquisition of RagingBull.com, LLC. The acquisition was previously completed on June 8, 2026, and this filing serves as a mandatory regulatory update to include the target company's historical financial performance.
Rapid Micro Biosystems M&A Deal with Merck KGaA, Darmstadt, Germany
Rapid Micro Biosystems has entered into a definitive agreement to be acquired by Merck KGaA, Darmstadt, Germany. The acquisition will be conducted via a tender offer and aims to accelerate the global adoption of Rapid's Growth Direct platform within Merck's Life Science business.
Counterparty
Merck KGaA, Darmstadt, Germany
“We are pleased to report 22% third quarter total revenue growth driven by both our Product and Service businesses. I am also particularly pleased with the continued progress in our gross margin expansion initiatives, which resulted in a third quarter total gross margin of 25%, including record Product and Service gross margins.”
Rob Spignesi, President and CEO
“I'm incredibly proud of what the Rapid Micro team has accomplished and the impact the Growth Direct platform is having across pharmaceutical manufacturing globally. Over the past 18 months, we have built a strong partnership with Merck KGaA, Darmstadt, Germany centered on a shared commitment to innovation and helping customers modernize quality control workflows. We are confident that joining the Life Science business of Merck KGaA, Darmstadt, Germany will significantly expand the Growth Direct's reach, accelerate adoption of the Growth Direct platform and more fully serve our combined global customer base.”
Cion Investment M&A Deal with BC Partners Advisors L.P.
BC Partners Credit has signed a definitive agreement to acquire a majority controlling interest in CION Investment Management (CIM), the external investment adviser to CION Investment Corporation. CIM will continue to operate independently with its current leadership and investment teams remaining in place, while gaining access to BC Partners' $10 billion private credit platform and origination capabilities. The transaction is expected to close in the first half of 2027, subject to customary conditions and shareholder approval of a new investment advisory agreement.
Air Industries Group M&A Deal with Tenax Aerospace Acquisition, LLC
Air Industries Group (AIRI) issued a reminder for a special meeting of stockholders on November 18, 2026, to vote on its proposed merger with Tenax Aerospace Acquisition. Upon closing, Tenax members will own approximately 96% of the combined company, and Tenax will fund the repayment of approximately $26.1 million of AIRI's debt.